Evaluation of BRCA1 as a Novel Therapeutic Strategy for Endothelial Dysfunction and Atherosclerosis

BRCA1 作为内皮功能障碍和动脉粥样硬化新治疗策略的评估

• 批准号: 184823
• 负责人: Verma Subodh S
• 金额: $ 10.93万
• 依托单位: Unity Health Toronto
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2009
• 资助国家: 加拿大
• 起止时间: 2009-04-01 至 2010-04-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=184823&lang=en
• 关键词: Atherosclerosis; Brca1; Endothelial Cells

The hardening of arteries (atherosclerosis) is one of the main ways that cardiovascular disease can lead to death. Atherosclerosis starts when the cells lining the inside of blood vessels (endothelial cells) become damaged and the blood vessel loses the a

动脉硬化（动脉粥样硬化）是心血管疾病导致死亡的主要途径之一。动脉粥样硬化开始时，内衬血管内的细胞（内皮细胞）受损，血管失去了血管内皮细胞。